Trial Profile
A Phase 1, Open Label, Exploratory Study for the Intra-operative Imaging of Folate Receptor Alpha Positive Ovarian and Lung Cancer using the Tumor Specific Imaging Agent EC17
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jul 2015
Price :
$35
*
At a glance
- Drugs Folate-fluorescein isothiocyanate conjugate (Primary)
- Indications Non-small cell lung cancer; Ovarian cancer
- Focus Adverse reactions; Diagnostic use
- 04 Jul 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 25 Sep 2014 New trial record